Clinical Trial Update: Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating belimumab to prevent chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Graft Vs Host Disease, Graft-versus-host-disease | Phase 1 | Status: COMPLETED | Results posted: 2026-04-20